Genenta Science Regains Compliance with Nasdaq Minimum Bid Price Requirement

On June 16, 2026, Genenta Science S.p.A. announced that it has regained compliance with the Nasdaq minimum bid price requirement. The company received formal notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC on June 15, 2026, confirming it met the standards of Nasdaq Listing Rule 5550(a)(2). The compliance issue was originally disclosed following a notification on April 10, 2026, which stated that the company's American Depositary Shares (ADSs) had closed below the $1.00 per share minimum for 30 consecutive business days. To rectify this, Genenta's ADSs maintained a closing bid price of at least $1.00 per share for 10 consecutive business days, specifically from June 1, 2026, through June 12, 2026. Nasdaq has officially closed the matter, and Genenta remains listed on the Nasdaq Capital Market. This regulatory milestone ensures the company's continued access to public capital markets under its current listing status.